The Market Herald | Avecho Biotechnology (ASX:AVE) releases results from its Phase I trial of CBD soft-ge
Avecho Biotechnology Limited (ASX:AVE) has been featured in The Market Herald, following the announcement of the results of our Phase I PK Study.